Prophylactic effect of chronic immunosuppression in a mouse model of CSF‐1 receptor‐related leukoencephalopathy
Open Access
Abstract
Mutations leading to colony-stimulating factor-1 receptor (CSF-1R) loss-of-function or haploinsufficiency cause CSF1R-related leukoencephalopathy (CRL), an adult-onset disease characterized by loss of myelin and neurodegeneration, for which there is no effective therapy. Symptom onset usually occurs in the fourth decade of life and the penetrance of disease in carriers is high. However, familial studies have identified a few carriers of pathogenic CSF1R mutations that remain asymptomatic even in their seventh decade of life, raising the possibility that the development and severity of disease might be influenced by environmental factors. Here we report new cases in which long-term glucocorticoid treatment is associated with asymptomatic status in elder carriers of pathogenic CSF-1R mutations. The main objective of the present study was to investigate the link between chronic immunosuppression initiated pre-symptomatically and resistance to the development of symptomatic CRL, in the Csf1r(+/-) mouse model. We show that chronic prednisone administration prevents the development of memory, motor coordination and social interaction deficits, as well as the demyelination, neurodegeneration and microgliosis associated with these deficits. These findings are in agreement with the preliminary clinical observations and support the concept that pre-symptomatic immunosuppression is protective in patients carrying pathogenic CSF1R variants associated with CRL. Proteomic analysis of microglia and oligodendrocytes indicates that prednisone suppresses processes involved in microglial activation and alleviates senescence and improves fitness of oligodendrocytes. This analysis also identifies new potential targets for therapeutic intervention.Keywords
Funding Information
- National Cancer Institute (P30CA013330)
- National Institutes of Health (R01NS091519)
This publication has 63 references indexed in Scilit:
- Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroidsNature Genetics, 2011
- Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonismProceedings of the National Academy of Sciences, 2011
- Annexin A1: A Central Player in the Anti-Inflammatory and Neuroprotective Role of MicrogliaThe Journal of Immunology, 2010
- CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelinationProceedings of the National Academy of Sciences, 2010
- Induction of macroautophagy by overexpression of the Parkinson's disease‐associated GPR37 receptorThe FASEB Journal, 2009
- Early deficits in motor coordination and cognitive dysfunction in a mouse model of the neurodegenerative lysosomal storage disorder, Sandhoff diseaseBehavioural Brain Research, 2008
- Platelet-Derived Growth Factor Promotes Repair of Chronically Demyelinated White MatterJournal of Neuropathology & Experimental Neurology, 2007
- Macromolecular Translocation Inhibitor II (Zn2+-binding Protein, Parathymosin) Interacts with the Glucocorticoid Receptor and Enhances Transcription in VivoJournal of Biological Chemistry, 2005
- Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defectsBlood, 2002
- Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.Journal of Clinical Investigation, 1998